|
1 Indications And Usage Nevirapine Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv-1) Infection In Adults And Pediatric Patients 15 Days And Older. [See Clinical Studies ( 14.1 , 14.2 )] Limitations Of Use: Based On Serious And Life-Threatening Hepatotoxicity Observed In Controlled And Uncontrolled Trials, Nevirapine Is Not Recommended To Be Initiated, Unless The Benefit Outweighs The Risk, In: • Adult Females With Cd4+ Cell Counts Greater Than 250 Cells/mm3 • Adult Males With Cd4+ Cell Counts Greater Than 400 Cells/mm3. [See Warnings And Precautions ( 5.1 )] Nevirapine Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv-1) Infection In Adults And Pediatric Patients 15 Days And Older. [See Clinical Studies( 14.1 , 14.2 ).] Limitations Of Use: Based On Serious And Life-Threatening Hepatotoxicity Observed In Controlled And Uncontrolled Trials, Nevirapine Is Not Recommended To Be Initiated, Unless The Benefit Outweighs The Risk, In: • Adult Females With Cd4+ Cell Counts Greater Than 250 Cells/mm3 • Adult Males With Cd4+ Cell Counts Greater Than 400 Cells/mm3. [See Warnings And Precautions ( 5.1 )]
|